科瑞技術(002957.SZ):目前主要開發了IGBT功率半導體相關的晶圓、輔料及相關工裝的貼裝及組裝設備
格隆匯12月15日丨有投資者於投資者互動平台向科瑞技術(002957.SZ)提問,“公司有對半導體設備提供精密零部件嗎?公司客户跨界廣泛,年報裏能細分説明下游個行業的收入佔比嗎?”,公司回覆稱,公司目前主要開發了IGBT功率半導體相關的晶圓、輔料及相關工裝的貼裝及組裝設備,公司將持續積累相關應用技術、積極拓展半導體相關設備的業務。相關經營情況請見公司對外披露的定期報吿及相關臨時公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.